Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Plasma cell 3Lymphoid 3Gynecologic 3Sarcoma 2Other hematologic neoplasm 2Myeloid 2Genitourinary 2Dermatologic 2CNS 2Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 2Vomiting 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Pain, Intractable 1Pain 1Neoplasms, Squamous Cell 1Nausea 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Deglutition Disorders 1Cancer Pain 1Anus Neoplasms 1

Interventions

Palonosetron 2fosaprepitant 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Olanzapine 1Electroacupuncture 1Dexamethasone 1Cisplatin 1Calcium Dobesilate 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Calcium Dobesilate × Head & Neck × Clear all
NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

University of Washington

Phase 2 Terminated
6 enrolled 5 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡